BREYANZI has significant market potential due to its innovative approach as a CD19-directed chimeric antigen receptor (CAR) T-cell therapy. The growing prevalence of hematologic malignancies ...

DelveInsight's 'BREYANZI Market Size, Forecast, and Market Insight Report' highlights the details around BREYANZI, a CD19-directed CAR ...

Abecma is being jointly developed and commercialized in the U.S. as part of a co-development, co-promotion, and profit share ...

Bristol-Myers Squibb's stock surged to a new 52-week high, trading at $61.90 after closing at $60.18. Analysts have updated ...

ReviveMed's AI platform analyzes metabolite data, revealing insights into diseases and streamlining drug development for ...

Actor Taye Diggs sits down with TODAY’s Jenna Bush Hager and guest co-host Regina Hall to talk about Bristol Myers Squibb, an organization that he is an ambassador for and opens up about how the ...

Although new U.S. tariffs on Canada, Mexico, and China are putting pressure on markets, investors are shifting toward ...

NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced it was named a Customers' Choice in the 2025 Gartner Peer Insights ?Voice of the Customer' for Primary Storage ...

PC era" aren't just buzzwords; they represent today's reality. Within the GIS industry, mobile internet and mobile GIS technology have transformed how we acquire, visualize, analyze, and ...

Just nine weeks after UnitedHealthcare CEO Brian Thompson was murdered on a weekday morning on a busy street, the luminaries ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...